Cargando…
Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma
BACKGROUND: Podoplanin is a type I transmembrane sialomucin-like glycoprotein that is specifically expressed in lymphatic endothelial cells. Studies have shown that assessment of podoplanin expression in the epithelial cells can be used to predict the malignant transformation of potentially malignan...
Autores principales: | A G, Deepa, Janardanan-Nair, Bindu, B R, Varun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794119/ https://www.ncbi.nlm.nih.gov/pubmed/29410757 http://dx.doi.org/10.4317/jced.54213 |
Ejemplares similares
-
Expression of Podoplanin in Different Grades of Oral Squamous Cell Carcinoma
por: Prasad, B, et al.
Publicado: (2015) -
Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
por: Patil, Ashok, et al.
Publicado: (2015) -
The Role of Podoplanin in the Lymphangiogenesis of Oral Squamous Carcinomas
por: CIUREA, R.N., et al.
Publicado: (2015) -
A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study
por: Srinivasan, Vaishnavi, et al.
Publicado: (2023) -
An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation
por: Aiswarya, A, et al.
Publicado: (2019)